| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6065377 | Journal of Allergy and Clinical Immunology | 2014 | 8 Pages |
Abstract
This is the first successful North American confirmatory phase 3 clinical trial to demonstrate the safety and efficacy of a sublingual standardized ragweed allergen immunotherapy liquid extract for the treatment of ARC.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Peter S. MD, Robert E. PhD, Peter MD, Deborah MD, Pina MSc, Brad BS, Michael MD, Terrance C. MD,